Latest filing published 01 Jun 2026 for Kane Biotech Inc..
Filing timeline
BuySaleInsider track record
Raymond David Eugene Dupuis: trading record in brief
All filings by Raymond David Eugene Dupuis on record concern Kane Biotech Inc. Over a trading history stretching from 15 January 2018 to 28 May 2026, the count stands at 9 filings.
Every open-market trade on record is a purchase: 4 purchases worth €24k, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Outside the open market, there are 2 option exercises.
The median purchase comes to €5,081. The 3 purchases reviewed show no overlap with other insiders buying the same stock within a month.
The newest entry dates from 1 June 2026: a transaction, in Kane Biotech Inc. The most recent open-market purchase was published on 13 September 2023, 1,154 days ago. Filings reach the SEDI feed a median of 2 days after the trade. This delay matters because a trade only becomes useful information once it is public. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Raymond David Eugene Dupuis
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 62,500 sharesWarrantsTSXSEDI:4726092
- 1,750,000 sharesOptionsTSXSEDI:4725989
- 100,000 shares@ CA$0.1022.4% of flowCommon SharesTSXSEDI:4439069
- 125,000 shares@ CA$0.0814.5% of flowCommon SharesTSXSEDI:4182719Canonical exit: 10 Dec 2023 (T+90)
- 100,000 sharesCommon SharesTSXSEDI:3749685
- 115,000 shares@ CA$0.14Common SharesTSXSEDI:3639116Canonical exit: 7 Mar 2021 (T+90)
- 178,571 shares@ CA$0.14100.0% of flowCommon SharesTSXSEDI:3472199
- 76,500 shares@ CA$0.06516.2% of flowCommon SharesTSXSEDI:3253791Canonical exit: 20 Jan 2019 (T+90)
- 50,000 shares@ CA$0.0912.6% of flowCommon SharesTSXSEDI:3118718Canonical exit: 15 Apr 2018 (T+90)
9 of 9 declarations